Press release
Anxiety and Depression Treatment Market
Anxiety and Depression Treatment Market accounted for US$ 10.89 billion in 2020 and is estimated to be US$ 13.85 billion by 2030 and is anticipated to register a CAGR of 2.7%. Anxiety and Depression are two types of mood disorders. Anxiety creates feelings of nervousness, worry or dread. Feeling of sadness, reduced energy and feeling loneliness are symptoms of Depression. Anxiety & Depression lead to chronic fatigue, tiredness & lack of energy. Due to over stress and overthinking the human body cannot handle the emotions and begins to shut down which is manifested by extreme fatigue and tiredness. Covid-19 Pandemic has increased the mental illness among people. Thus, newly drugs, therapies in market are highly recommended.The report "Global Anxiety and Depression Treatment Market By Product (Antidepressant Drugs, SSRIs (Selective Serotonin Reuptake Inhibitor), SNRIs (Serotonin-Norepinephrine Reuptake Drug), Benzodiazepine, Devices and Therapy), By Indication (MDD (Major Depressive Disorder), OCD (Obsessive-Compulsive Disorder), Phobia), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030"
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Anxiety-and-Depression-Treatment-Market-4899
Key Highlights:
• March 2022, COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. The wakeup call to all countries to step up mental health services and support. Increase in drug development has raised due to pandemic.
• March 2019, FDA approves new nasal spray medication for treatment -resistant depression; available only at a certified doctor's office or clinic. FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them.
Analyst View:
Due to increase in prevalence of anxiety and depression worldwide. Newly medications is must which are easily available & cost affordable for patients. Increase in research and development to bring up new drug available in market is highly recommended. This can give the boost growth in target market.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "Global Anxiety and Depression Treatment Market By Product (Antidepressant Drugs, SSRIs (Selective Serotonin Reuptake Inhibitor), SNRIs (Serotonin-Norepinephrine Reuptake Drug), Benzodiazepine, Devices and Therapy), By Indication (MDD (Major Depressive Disorder), OCD (Obsessive-Compulsive Disorder, Phobia), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030"
Click To Get Sample Report:-
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4899
Global Anxiety and Depression Market, By Product:
• Antidepressant Drugs
• SSRIs (Selective Serotonin Reuptake Inhibitor)
• SNRIs (Serotonin Norepinephrine Reuptake Drug)
• Benzodiazepine
• Devices
• Therapy
Global Anxiety and Depression Market, By Indication:
• MDD (Major Depressive Disorder)
• OCD (Obsessive-Compulsive Disorder)
• Phobia
Global Anxiety and Depression Market, By Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Key Market Insights from the report:
Global Anxiety and Depression Treatment Market accounted for US$ 10.89 billion in 2020 and is estimated to be US$ 13.85 billion by 2030 and is anticipated to register a CAGR of 2.7%. The Global Anxiety and Depression Treatment Market is segmented based on Product, Indication, Distribution Channel and Region.
• Based on Product, Global Anxiety and Depression Treatment Market is segmented into Antidepressant drugs, SSRIs (Selective Serotonin Reuptake Inhibitor), SNRIs (Serotonin-Norepinephrine Reuptake Drug), Benzodiazepine, Devices and Therapy.
• Based on Indication, Global Anxiety and Depression Treatment Market is segmented into MDD (Major Depressive Disorder), OCD (Obsessive-Compulsive Disorder, Phobia.
• Based on distribution channel, Global Anxiety and Depression Treatment Market is classified into hospital pharmacy, retail pharmacy, and online pharmacy and others.
• By Region, the Global Anxiety and Depression Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Competitive Landscape & their strategies of Anxiety and Depression Treatment:
The prominent players operating in the Global Anxiety and Depression Treatment Market includes, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, Merck & Co. Inc., AstraZeneca, Bristol-Myers Sqibb, Lundbeck A/S, GlaxoSmithKline plc., Novartis AG, Sanofi, Cipla Ltd., Glenmark Life Sciences Limited, Lupin Limited, Sun Pharmaceutical Industries Ltd., Intas Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co. Ltd., and Others.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
964 E. BadilloStreet #2042 Covina, CA 91724
US toll free: +1 860 531 2701
Rest of world: + 91 7775049802
Email:sales@prophecymarketinsights.com
Website:www.prophecymarketinsights.com
About Us: Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anxiety and Depression Treatment Market here
News-ID: 2764865 • Views: …
More Releases from Prophecy Market Insights

Autonomous Ships Market is estimated to be USD 11.6 Billion by 2035 and is antic …
Author: Shweta R., Business Development Specialist
Introduction
The Autonomous Ships Market is rapidly emerging as a transformative force in the global maritime industry. With advancements in artificial intelligence (AI), sensor technology, big data analytics, and navigation systems, autonomous vessels are being developed to improve efficiency, safety, and sustainability. The push toward smart shipping and green maritime solutions is expected to accelerate the adoption of autonomous ships in the coming years.
👉 Get Your…

Mesh Gateway Market Growth Outlook to 2035 | Size, Share, Trends, and Opportunit …
The Mesh Gateway Market is projected to expand significantly, reaching USD 4.7 Billion by 2035, compared to USD 1.5 Billion in 2024, at a strong CAGR of 11.8% during the forecast period. Mesh gateways play a critical role in enabling reliable, scalable, and flexible connectivity across smart infrastructure, industrial automation, and IoT ecosystems. With industries embracing Industry 4.0, predictive maintenance, and smart city initiatives, demand for mesh gateways is expected…

Enzymatic DNA Synthesis Market Growth Outlook to 2035 | Size, Share, Trends, and …
The Enzymatic DNA Synthesis Market is projected to witness significant growth, reaching an estimated USD 16.0 Billion by 2035, expanding from a valuation of USD 5.89 Billion in 2024, at a robust CAGR of 10.6% during the forecast period. Enzymatic DNA synthesis (EDS) is increasingly gaining momentum as a next-generation technology over traditional chemical DNA synthesis, owing to its higher accuracy, environmental sustainability, and ability to synthesize longer DNA sequences.
Download…

Pocket Printer Market: Global Trends, Size, Growth, and Forecast 2025-2035
Author: Shweta R., Business Development Specialist
Introduction
The Pocket Printer Market is rapidly gaining traction as consumers and businesses embrace portability, wireless connectivity, and instant printing solutions. Pocket printers, also known as mobile or portable printers, are compact, lightweight, and designed for on-the-go usage, catering to travelers, students, professionals, and creative enthusiasts. With the rise in remote work, digital nomad culture, and demand for convenience, the global pocket printer market is forecasted…
More Releases for Anxiety
The Anxiety Dr. Tackles Anxiety and Menopause from The Inside Out
With a non-toxic skincare product range and a meditation center, Te Sana makes wellness more attainable for American women
Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXcelSYcl5By5c5HZ4qwewxzcditBU_QOzGzI8CQiGS1PERRjp_24ch2zmAmmObvbwpb6LVSM4zlFmFZ3D0VfOBRuu2n3EojxMuhYqhLKQueRPnZjK5_OM3lHL6IPJDz7xHg40IKjQ?key=M6Cn1-UbtO5NZUXRnBaqnQ
HOUSTON - May 16, 2025 - Te Sana Wellness [https://www.tesanawellness.com/] has launched a new collection of non-toxic skincare products, empowering American women to say goodbye to overwhelming anxiety, perimenopausal, and menopausal symptoms. Launched by Dr. Lisa Cortez (The Anxiety Dr.), Te Sana Wellness is driven by a mission to offer clients…
How the Anxiety Disorders Market Is Growing in 2025 | What's New Treatments Are …
The anxiety disorders market size was valued at US$ 8.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the 7MM to reach US$ 11.9 Billion by 2035, exhibiting a growth rate (CAGR) of 3.36% during 2025-2035.
In 2025, a rapid surge is experienced in the anxiety disorders market as more and more individuals become its victims, the level of awareness, and…
Key Generalized Anxiety Disorder Market Trend for 2025-2034: Innovative Drug Dev …
"What Is the Future Outlook for the Generalized Anxiety Disorder Market's Size and Growth Rate?
The generalized anxiety disorder market will grow from $7.76 billion in 2024 to $8.01 billion in 2025, at a CAGR of 3.2%. Growth is driven by increased mental health awareness, pharmaceutical advances, the popularity of cognitive-behavioral therapy (CBT), and the stressful lifestyle changes of modern society.
The generalized anxiety disorder market is expected to reach $9.32 billion…
Social Anxiety Coach Katy Morin Announces New Resources to Help People Overcome …
Social Anxiety Antidote is a specialized platform run by Katy Morin, a dedicated Social Anxiety Coach and Certified Hypnotherapist. It offers resources and guidance for individuals struggling with social anxiety. This platform focuses on creating a safe, supportive environment where users can access personalized programs and techniques to overcome their fears and build confidence. Katy leverages her expertise to provide a path toward a more confident and less anxious life…
Free Hypnosis Download for Coronavirus Anxiety
Eli Bliliuos, founder and President, of NYC Hypnosis Center has just released a free hypnosis download to help anyone who is suffering from anxiety and stress due to the Coronavirus pandemic.
The free Hypnosis MP3 for Coronavirus Anxiety (24 hours only), called "Clear Your Mind", can provide a break from the repetitive thoughts related to the outbreak. It can help program the mind to recognize that this Coronavirus pandemic will…
Get Anxiety Relief without Medication
A lot of people look for anti-depressants for anxiety relief but these anti-depressants are often a cause of the manic symptoms, which is a result of overproduction of neurotransmitters. Panic attacks can happen to anybody during any phase of time and often it comes crashing against your body and mind. The syndrome has a number of symptoms like fast and hard heart beating, a sense of losing control, shortness of…